- Bionik Laboratories ( OTCPK:BNKL ) appoints Richard Russo, Jr. as CEO and President and Dan Gonsalves as CFO and executive VP.
- Richard Russo previously served as the CFO of the company and Dan Gonsalves was the company's Corporate Controller.
- Both appointments are effective immediately.
-
The company continues to ramp up its recently announced growth strategy featuring ‘Centers of Excellence’ for Neuro-Recovery Care to broaden access to robotic rehabilitation
-
“The global neurorehabilitation devices market alone is projected to reach $4.9 billion by 2028. With a growing installed base of InMotion devices driving awareness and usage and a global distribution strategy, Bionik expects to build on its upward trajectory.” said Dan Gonsalves, CFO and Executive Vice President at Bionik.
For further details see:
Bionik laboratories appoints new CEO and CFO